Copaxone
NDC 68546-317, Glatiramer Acetate, injection, solution, from Teva Neuroscience, Inc..
- Product NDC
- 68546-317
- Status
- Listed
- Labeler
- Teva Neuroscience, Inc.
- Dosage form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA020622
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/68546-317 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- GLATIRAMER ACETATE20 mg/mL
| Package NDC | NDC-11 | Package |
|---|---|---|
| 68546-317-30 | 68546031730 | 30 BLISTER PACK in 1 CARTON (68546-317-30) / 1 SYRINGE, GLASS in 1 BLISTER PACK / 1 mL in 1 SYRINGE, GLASS |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/aa88f583-4f5f-433b-80b4-1f4c9fb28357NADAC price for package 68546031730
GET /v1/drugs/nadac/68546031730
Use it
Look up 68546-317 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/68546-317 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 68546-317. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.